TY  - JOUR
AU  - Majidi, Azam
AU  - Rinaldi, Sabina
AU  - Biessy, Carine
AU  - Vozar, Beatrice
AU  - Truong, Therese
AU  - Turzanski Fortner, Renée
AU  - Le Cornet, Charlotte
AU  - Schulze, Matthias B
AU  - Panico, Camilla
AU  - Tumino, Rosario
AU  - Masala, Giovanna
AU  - Ricceri, Fulvio
AU  - Vener, Claudia
AU  - Sánchez, Maria-José
AU  - Zamora-Ros, Raúl
AU  - Crous-Bou, Marta
AU  - Colorado-Yohar, Sandra M
AU  - Guevara, Marcela
AU  - Israelsson, Pernilla
AU  - Travis, Ruth
AU  - Riboli, Elio
AU  - Fournier, Agnès
AU  - Dossus, Laure
TI  - Thyroid hormones and epithelial ovarian cancer risk and survival: results from the EPIC study.
JO  - Journal of the National Cancer Institute
VL  - nn
SN  - 0027-8874
CY  - Oxford
PB  - Oxford Univ. Press
M1  - DKFZ-2025-01698
SP  - nn
PY  - 2025
AB  - Thyroid-stimulating hormone (TSH) and thyroid hormones (free triiodothyronine[fT3] and free thyroxine[fT4]) may influence cancer outcomes, but evidence for ovarian cancer is limited.We conducted a nested case-control study comparing 578 epithelial ovarian cancer (EOC) cases to matched controls within the European Prospective Investigation into Cancer and Nutrition (EPIC). To examine associations between circulating TSH, fT3, and fT4 levels and EOC risk, we estimated risk ratios (RRs) and 95
LB  - PUB:(DE-HGF)16
C6  - pmid:40811636
DO  - DOI:10.1093/jnci/djaf222
UR  - https://inrepo02.dkfz.de/record/303508
ER  -